This work is licensed under a
Creative Commons Attribution 4.0 International License
 Singh SP, Singh, V, Kar N. Efficacy of agomelatine in major depressive disorder meta-analysis and appraisal. International Journal of Neuropsychopharmacology, 2012; 15: 417-428.DOI: 10.1017/s1461145711001301
 Girish, MB, Bhuvana K, Nagesh RG, Sarala, N. A novel atypical antidepressant drug: Agomelatine – A review. International Journal of Pharmaceutical and Biomedical Research, 2010; 1(3): 113-116.
 Girstaute D, Paul L, Tim J, Cecilia G, Elisabeth M, Johan D. Chronic Stress and Antidepressant Agomelatine Induce Region-Specific Changes in Synapsin I Expression in the Rat Brain. Journal of Neuroscience Research, 2011; 89: 1646-1657.DOI: 10.1002/jnr.22697
 Patil SR, Nerukar KK, Kalamkar AM, Pukale V, Mangaonkar KV, Pingale SG. Validated LC-MS/MS method for quantification of agomelatine in human plasma and its application in a pharmaceutical study. Journal of Mass Spectrometry, 2012; 47: 23-28.DOI: 10.1002/jms.2020
 Rao VP, Prabhakar T, Naveen RC, Ramakrishna S, Trinath G. Clinical and pharmacological review on novel melatonergic antidepressant: Agomelatine. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 2010; 1(2): 446-450.
 Singh, S., Bakshi, M. Guidance on conduct of stress tests to determine inherent stability of drugs. Pharmaceutical Technology On-line, 2000; 24: 1-14.
 Ram VR, Dave PN, Joshi HS. Development and validation of a stability indicating HPLC assay method for simultaneously determination of Spironolactone and Furosemide in tablet formulation. Journal of chromatographic science, 2012; 00: 1-6.DOI: 10.1093/chromsci/bms062
 Saranjit S, Baljinder S, Rakesh B, Lalit W, Rahul S. Stress degradation studies on ezetimibe and development of a validated stability-indicating HPLC assay. Journal of Pharmaceutical and Biomedical Analysi, 2006; 41: 1037-1040.DOI: 10.1016/j.jpba.2006.01.030
 YaravedaLathareddy, Naidu SrinivasaRao. Stability-Indicating RP-HPLC Method and Its Validation for Analysis of Metformin &Sitagliptin in Bulk and Pharmaceutical Dosage Form, World Journal of Pharmacy and Pharmaceutical Sciences, 2013; 2(5): 3691-3709.DOI: 10.20959/wjpps20178-9786
 Monika B, Saranjit S. Development of validated stability-indicating assay methodscritical review. Journal of Pharmaceutical and Biomedical Analysis, 2002; 28: 10111040.DOI: 10.1016/s0731-7085(02)00047-x
 Xue-jun H, Ren Z, Wang J, Liu J, Du Y, Quio H. Determenation of Agomelatine by RP-HPLC. HuaxiYaoxueZazhi, 2010; 25(2): 204-205.
 Ning M. HPLC method for separating and analyzing agomelatine intermediate and final product thereof. Faming ZhuanliShenquingGongkaiShuomingshu, 2008; CN 101206200 A 20080625.
 Kher GJ, Ram VR, Dubal KD, Bapodra AH, Joshi HS. Validation of a StabilityIndicating LC Method for Assay of Lefunomide in Tablets and for Determination of Content Uniformity. International Journal of ChemTech Research, 2011: 3(2): 523530.